The obesity drug price wars are finally starting. After being publicly lambasted for the high cost of their weight-loss shots ...

Obesity can lead to a chronic inflammatory state within the body. What drives this inflammation? Does inflammation, in turn, ...

Navigating ineffective weight management treatment is a sensitive process that requires acknowledgement of bias from both ...

for example on satiety, the gut microbiome and body composition.” General obesity is typically assessed using body mass index (BMI), with the World Health Organization (WHO) defining obesity as a BMI ...

Apr. 28, 2025 — In the past 20 years, the average rate of obesity among adults in the United States has risen by approximately 30 percent, but the rate of those with the most severe forms of ...

Adults who developed severe obesity before the age of 18 are nearly three times more likely than those who developed the condition later to be subjected to severe experienced weight stigma (EWS ...

Patients who receive a new diagnosis should be offered resources, such as fact sheets, brochures ... “I think this is a great example to clinics that may have small staffs and no dedicated ...

Within Novo Nordisk's comprehensive business update to investors, attention latched onto early data for an oral obesity therapy that outperformed the company’s big-selling GLP-1 agonist Wegovy ...

The FDA has said it has agreed to reconsider its decision to prevent compounding pharmacies from producing and selling versions of Eli Lilly's diabetes and obesity drug tirzepatide. The US ...

This guide walks you through a simple, actionable plan—plus includes a free template to help you stay organized and put your new strategy into motion. Download your free plan below and read ...

Forbes contributors publish independent expert analyses and insights. Hank Cardello covers issues impacting food companies and consumers.

Pfizer Inc. is cutting at least another $1.2 billion from its spending while the company searches for its next big hit after the failure of its obesity pill. The New York City-based drugmaker’s ...